Education
About Us
Working with TipRanks
Follow Us
LENSAR (LNSR)
NASDAQ:LNSR
LNSR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.50 - $17.31
Previous CloseN/A
Volume40.10K
Average Volume (3M)116.73K
Market Cap
$156.07M
Enterprise ValueN/A
Total Cash (Recent Filing)$22.45M
Total Debt (Recent Filing)$2.61M
Price to Earnings (P/E)―
Beta0.82
Next Earnings
Aug 06, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.32
Shares Outstanding11,904,989
10 Day Avg. Volume90,452
30 Day Avg. Volume116,729
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)31.02
Price to Sales (P/S)0.00
P/FCF Ratio-62.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$15.00Price Target Upside14.42% Upside
Rating ConsensusHold
Number of Analyst Covering2
LENSAR News
PremiumCompany Announcements
FTC Extends Waiting Period for LENSAR Merger
PremiumCompany Announcements
LENSAR Announces Merger with Alcon Research
PremiumCompany Announcements
LENSAR Reports Strong Q1 2025 Growth Amid Merger Plans
PremiumCompany Announcements
LENSAR Announces Merger Agreement with AlconBulls Say, Bears Say
Bulls Say
Acquisition And PartnershipsThe announced acquisition by Alcon is seen as a positive outcome for both Lensar and Alcon, with Lensar experiencing strong adoption of its ALLY System in the cataract surgery market.
Financial PerformanceThe company reported Q4 revenue of $16.7M, which was 38% higher than the previous year and above market expectations.
Market ExpansionLNSR highlighted that ~75% of US FY24 placements have come from new customers, indicating strong market expansion and competitive positioning.
Bears Say
Growth ChallengesLensar is required to achieve substantial procedure growth to meet the terms of the acquisition agreement, which may pose challenges.
Profitability ChallengesGross margins are lower due to higher capital sales, which impacts the company's profitability.
Valuation ConcernsThe stock is rated as Neutral because the implied takeout value is seen as fairly valued, indicating limited upside potential.
Options Prices
Currently, No data available
---
Ownership Overview
13.99% Insiders
9.47% Mutual Funds
12.95% Other Institutional Investors
59.46% Public Companies and Individual Investors
LNSR FAQ
What was LENSAR’s price range in the past 12 months?
LENSAR lowest stock price was $3.50 and its highest was $17.31 in the past 12 months.
What is LENSAR’s market cap?
LENSAR’s market cap is $156.07M.
When is LENSAR’s upcoming earnings report date?
LENSAR’s upcoming earnings report date is Aug 06, 2025 which is in 57 days.
How were LENSAR’s earnings last quarter?
LENSAR released its earnings results on May 08, 2025. The company reported -$2.32 earnings per share for the quarter, missing the consensus estimate of -$0.154 by -$2.166.
Is LENSAR overvalued?
According to Wall Street analysts LENSAR’s price is currently Undervalued.
Does LENSAR pay dividends?
LENSAR does not currently pay dividends.
What is LENSAR’s EPS estimate?
LENSAR’s EPS estimate is -0.08.
How many shares outstanding does LENSAR have?
LENSAR has 11,904,989 shares outstanding.
What happened to LENSAR’s price movement after its last earnings report?
LENSAR reported an EPS of -$2.32 in its last earnings report, missing expectations of -$0.154. Following the earnings report the stock price went down -0.145%.
Which hedge fund is a major shareholder of LENSAR?
Currently, no hedge funds are holding shares in LNSR
LENSAR Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$15.00 (14.42% Upside)
$15.00 (14.42% Upside)
Blogger Sentiment
Bullish
LNSR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 55.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 10.1%
Last 30 Days ▼ 30.3%
Last 30 Days ▼ 30.3%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
176.00%
12-Months-Change
Fundamentals
Return on Equity
-304.05%
Trailing 12-Months
Asset Growth
10.32%
Trailing 12-Months
Company Description
LENSAR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
LNSR Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong performance in 2024, with record-breaking revenue growth, significant market share gains, and positive adjusted EBITDA. However, there is a notable decrease in recurring revenue percentage and a substantial net loss due to a non-cash charge. The company remains optimistic about future growth and market expansion.Read More>LNSR Stock 12 Month Forecast
Average Price Target
$15.00
▲(14.42%Upside)